• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观察性病例系列:六例神经外科感染性休克患者在接受标准治疗联合血液净化治疗后临床状况改善。

Observational case series: six neurosurgical patients with septic shock demonstrating clinical improvement after a combination of standard care and blood purification.

机构信息

Federal State Autonomous Institution N. N. Burdenko National Medical Research Center of Neurosurgery of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.

Federal State Budget Educational Institution of Higher Education M. V. Lomonosov Moscow State University, Moscow, Russian Federation.

出版信息

Eur J Med Res. 2021 Dec 20;26(1):151. doi: 10.1186/s40001-021-00614-7.

DOI:10.1186/s40001-021-00614-7
PMID:34930484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8691076/
Abstract

BACKGROUND

For patients with primary brain injury, septic shock is especially dangerous due to the possibility of secondary cerebral damage. The key factor of sepsis-associated brain injury is inflammatory mediators, pathogen and damage-associated molecular patterns (PAMPs, DAMPs) release. Theoretically, blood purification may be beneficial for patients with primary brain injury due to its possibility for fast removal of inflammatory mediators.

CASE PRESENTATION

We report on six post-neurosurgery septic shock patients treated with combined blood purification (CBP), which included CRRT with high adsorption capacity membrane in combination with CytoSorb adsorber. Clinical improvement in the course of CBP was registered in all patients. Three patients had a stable clinical improvement; the other three patients had only a transient improvement due to underlying neurological and cardiac deficits aggravation. We observed septic shock reversal in four patients. The key observations of the case series are a significant decrease in MOF severity (measured by SOFA score) and in catecholamine need (not statistically significant). By the end of CBP we observed a significant decrease in blood lactate, PCT and IL-6 levels. Two patients demonstrated level of consciousness increase in the setting of CBP therapy measured by GCS and FOUR score.

CONCLUSION

This case series demonstrates that CBP therapy may have a role for septic shock patients with primary brain injury.

摘要

背景

对于原发性脑损伤患者,由于可能发生继发性脑损伤,感染性休克尤其危险。与脓毒症相关的脑损伤的关键因素是炎症介质、病原体和损伤相关分子模式(PAMPs、DAMPs)的释放。理论上,由于可能快速清除炎症介质,血液净化可能对原发性脑损伤患者有益。

病例介绍

我们报告了 6 例神经外科手术后感染性休克患者接受联合血液净化(CBP)治疗的情况,其中包括高通量吸附膜 CRRT 与 CytoSorb 吸附剂联合使用。在 CBP 过程中,所有患者的临床状况均得到改善。3 例患者的临床改善稳定,另外 3 例患者仅因潜在的神经和心脏缺陷加重而出现短暂改善。我们观察到 4 例患者的感染性休克得到逆转。本病例系列的主要观察结果是多器官功能衰竭严重程度(通过 SOFA 评分衡量)和儿茶酚胺需求显著降低(无统计学意义)。在 CBP 结束时,我们观察到血液乳酸、PCT 和 IL-6 水平显著降低。在 CBP 治疗期间,2 例患者的意识水平增加,通过 GCS 和 FOUR 评分进行评估。

结论

本病例系列表明,CBP 治疗可能对原发性脑损伤合并感染性休克患者有作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/37ac1c0ae9f8/40001_2021_614_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/5f8128224a3c/40001_2021_614_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/1b72835346e5/40001_2021_614_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/23f386ea5469/40001_2021_614_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/f534061e0a4a/40001_2021_614_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/34c462925c4f/40001_2021_614_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/37ac1c0ae9f8/40001_2021_614_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/5f8128224a3c/40001_2021_614_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/1b72835346e5/40001_2021_614_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/23f386ea5469/40001_2021_614_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/f534061e0a4a/40001_2021_614_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/34c462925c4f/40001_2021_614_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0470/8691076/37ac1c0ae9f8/40001_2021_614_Fig6_HTML.jpg

相似文献

1
Observational case series: six neurosurgical patients with septic shock demonstrating clinical improvement after a combination of standard care and blood purification.观察性病例系列:六例神经外科感染性休克患者在接受标准治疗联合血液净化治疗后临床状况改善。
Eur J Med Res. 2021 Dec 20;26(1):151. doi: 10.1186/s40001-021-00614-7.
2
Hemoperfusion with Cytosorb in pediatric patients with septic shock: A retrospective observational study.细胞因子吸附剂 Cytosorb 用于感染性休克儿童患者的血液灌流:一项回顾性观察研究。
Int J Artif Organs. 2020 Sep;43(9):587-593. doi: 10.1177/0391398820902469. Epub 2020 Jan 31.
3
Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb) in the management of septic shock: A retrospective observational study.体外细胞因子吸附疗法(CytoSorb)血液吸附治疗感染性休克:一项回顾性观察研究。
Int J Artif Organs. 2020 Jun;43(6):372-378. doi: 10.1177/0391398819891739. Epub 2019 Dec 23.
4
Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.腹部感染性休克 - 内毒素吸附治疗(ASSET) - 使用Alteco® LPS吸附剂清除腹部和泌尿生殖系统感染性休克中的内毒素:一项双盲、随机、安慰剂对照试验的研究方案
Trials. 2016 Dec 8;17(1):587. doi: 10.1186/s13063-016-1723-4.
5
Hemoadsorption by CytoSorb in septic patients: a case series.细胞吸附剂(CytoSorb)对脓毒症患者的血液吸附:病例系列
Crit Care. 2017 Mar 27;21(1):74. doi: 10.1186/s13054-017-1662-9.
6
Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.体外细胞因子吸附:心脏手术后 AKI 合并感染性休克患者儿茶酚胺需求显著降低。
PLoS One. 2021 Feb 8;16(2):e0246299. doi: 10.1371/journal.pone.0246299. eCollection 2021.
7
Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study.脓毒性休克的细胞外细胞因子吸附:概念验证随机对照初步研究。
J Crit Care. 2019 Feb;49:172-178. doi: 10.1016/j.jcrc.2018.11.003. Epub 2018 Nov 10.
8
Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.体外细胞因子清除作为难治性感染性休克的挽救治疗:一项前瞻性单中心研究
J Artif Organs. 2017 Sep;20(3):252-259. doi: 10.1007/s10047-017-0967-4. Epub 2017 Jun 6.
9
Benefit of Hemoadsorption Therapy in Patients Suffering Sepsis-Associated Acute Kidney Injury: A Case Series.血液吸附疗法对脓毒症相关性急性肾损伤患者的获益:病例系列研究。
Blood Purif. 2022;51(10):823-830. doi: 10.1159/000521228. Epub 2022 Feb 2.
10
Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb.细胞因子、血流动力学和微循环变化在接受连续肾脏替代治疗和细胞因子吸附血液净化的脓毒症/脓毒性休克患者中。
Blood Purif. 2020;49(1-2):107-113. doi: 10.1159/000502540. Epub 2019 Aug 21.

引用本文的文献

1
High adsorption capacity of hemoperfusion on imipenem in critically ill patients with septic shock: a case report.血液灌流对脓毒性休克危重症患者亚胺培南的高吸附能力:一例报告。
BMC Infect Dis. 2024 Aug 31;24(1):894. doi: 10.1186/s12879-024-09774-3.
2
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications.脓毒症中的 PAMPs 和 DAMPs:分子特征及其潜在临床意义的综述。
Int J Mol Sci. 2024 Jan 12;25(2):962. doi: 10.3390/ijms25020962.

本文引用的文献

1
Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.细胞吸附疗法在感染性休克 ICU 患者中观察到的 28 天全因死亡率低于预期:一项倾向评分加权回顾性研究。
Crit Care. 2019 Sep 18;23(1):317. doi: 10.1186/s13054-019-2588-1.
2
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.细胞因子清除术联合 CytoSorb® 在心脏手术中的应用:一项前瞻性随机对照试验。
Crit Care. 2019 Apr 3;23(1):108. doi: 10.1186/s13054-019-2399-4.
3
The Effect of Continuous Renal Replacement Therapy with the AN69ST Membrane on Inflammatory Markers and the Level of Consciousness of Hemodialysis Patients with Stroke: Comparison with Hemodialysis with Low Blood Flow Rate.
AN69ST膜持续肾脏替代疗法对中风血液透析患者炎症标志物及意识水平的影响:与低血流量血液透析的比较
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2018 Dec 1;39(2-3):29-35. doi: 10.2478/prilozi-2018-0039.
4
Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study.脓毒性休克的细胞外细胞因子吸附:概念验证随机对照初步研究。
J Crit Care. 2019 Feb;49:172-178. doi: 10.1016/j.jcrc.2018.11.003. Epub 2018 Nov 10.
5
The clinical importance of a cytokine network in the acute phase of sepsis.细胞因子网络在脓毒症急性期的临床重要性。
Sci Rep. 2018 Sep 18;8(1):13995. doi: 10.1038/s41598-018-32275-8.
6
Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review.体外细胞因子血液吸附治疗的临床实用性:文献综述。
Blood Purif. 2018;46(4):337-349. doi: 10.1159/000492379. Epub 2018 Sep 3.
7
Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads.使用CytoSorb®吸附剂多孔聚合物微球从全血中广泛吸附脓毒症相关的病原体相关分子模式(PAMP)和损伤相关分子模式(DAMP)分子、霉菌毒素及细胞因子。
PLoS One. 2018 Jan 25;13(1):e0191676. doi: 10.1371/journal.pone.0191676. eCollection 2018.
8
International registry on the use of the CytoSorb® adsorber in ICU patients : Study protocol and preliminary results.关于CytoSorb®吸附器在重症监护病房患者中应用的国际注册研究:研究方案及初步结果。
Med Klin Intensivmed Notfmed. 2019 Nov;114(8):699-707. doi: 10.1007/s00063-017-0342-5. Epub 2017 Sep 4.
9
Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study.体外细胞因子清除作为难治性感染性休克的挽救治疗:一项前瞻性单中心研究
J Artif Organs. 2017 Sep;20(3):252-259. doi: 10.1007/s10047-017-0967-4. Epub 2017 Jun 6.
10
Systemic Inflammation as a Driver of Brain Injury: the Astrocyte as an Emerging Player.系统性炎症作为脑损伤的驱动因素:星形胶质细胞作为一个新兴的参与者。
Mol Neurobiol. 2018 Mar;55(3):2685-2695. doi: 10.1007/s12035-017-0526-2. Epub 2017 Apr 18.